Relationship Between Time of Day, Day of Week, Timeliness of Reperfusion, and In-Hospital Mortality for Patients With Acute ST-Segment Elevation Myocardial Infarction
Open Access
- 17 August 2005
- journal article
- research article
- Published by American Medical Association (AMA) in JAMA
- Vol. 294 (7), 803-812
- https://doi.org/10.1001/jama.294.7.803
Abstract
Reperfusion therapy with either fibrinolytic therapy or percutaneous coronary intervention (PCI) reduces mortality for eligible ST-segment elevation myocardial infarction (STEMI) patients.1-8 The shorter the time from symptom onset to treatment, the greater the survival benefit with either therapy.3,9-14 The choice between therapies should take into account reperfusion treatment times.15 Although prior studies16-18 have shown that door-to-balloon times for PCI are longer on evenings, nights, and weekends than on weekday days, several important questions remain. Prior studies neither assessed whether such variation was common to all types of hospitals nor did they determine where in the PCI process the delays occurred. In addition, these studies did not evaluate the impact of delayed door-to-balloon times on adherence to guideline recommended treatment times. Finally, previous studies focused on PCI and did not evaluate whether door-to-drug times for fibrinolytic therapy also varied by patient arrival period. Understanding the reasons for variation in reperfusion treatment times by patient arrival period, and whether such variation is common to all hospitals and to both fibrinolytic therapy and PCI, can inform the design and targeting of interventions to improve timely reperfusion.Keywords
This publication has 13 references indexed in Scilit:
- ACC/AHA Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction—Executive SummaryJournal of the American College of Cardiology, 2004
- Predictors of door-to-balloon delay in primary angioplastyThe American Journal of Cardiology, 2002
- Relationship of Symptom-Onset-to-Balloon Time and Door-to-Balloon Time With Mortality in Patients Undergoing Angioplasty for Acute Myocardial InfarctionJAMA, 2000
- Factors associated with delay in reperfusion therapy in elderly patients with acute myocardial infarction: Analysis of the Cooperative Cardiovascular ProjectAmerican Heart Journal, 2000
- Impact of time to treatment with tissue plasminogen activator on morbidity and mortality following acute myocardial infarction (the second National Registry of Myocardial Infarction)The American Journal of Cardiology, 1998
- Are the Results of Primary Percutaneous Transluminal Coronary Angioplasty for Acute Myocardial Infarction Different During the “Off” Hours?The American Journal of Cardiology, 1997
- Immediate Angioplasty Compared with the Administration of a Thrombolytic Agent Followed by Conservative Treatment for Myocardial InfarctionNew England Journal of Medicine, 1993
- A Comparison of Immediate Coronary Angioplasty with Intravenous Streptokinase in Acute Myocardial InfarctionNew England Journal of Medicine, 1993
- A Comparison of Immediate Angioplasty with Thrombolytic Therapy for Acute Myocardial InfarctionNew England Journal of Medicine, 1993
- A Prospective Randomized Clinical Trial of Intracoronary Streptokinase versus Coronary Angioplasty for Acute Myocardial InfarctionNew England Journal of Medicine, 1986